The Supreme Court has asked the centre, states and union territories to make acid attack offence a non-bailable offence and regulate sale of acid
The Supreme Court on Thursday directed states and union territories across the country to frame rules within three months for regulating sale of acids and other corrosive substances and make acid attack a non-bailable offence.
The apex court also directed that acid attack victims should be paid a compensation of at least Rs3 lakh by the concerned state government as an after-care and rehabilitation cost for such victims.
The bench also asked the central and state governments to work together and make the necessary rules under the Poison Act, 1919, for making acid attacks a non-bailable offence
A bench headed by Justice RM Lodha said, “The chief secretaries of the respective states and administrators of each union territory shall ensure compliance with this order expeditiously and frame rules within three months after receiving the model draft rules from the central government".
The bench, which was hearing a PIL filed in 2006 by Delhi-based acid attack victim Laxmi, who was then a minor, also passed a slew of interim directions on various issues including sale of acids.
Perusing the compensation schemes of 17 states and seven union territories, the bench observed that the amount which is being paid is “grossly inadequate”.
“It cannot be overlooked that acid attack victims need to undergo a series of plastic surgeries and other corrective treatment. Having regard to this, the Solicitor-General suggested to us that the compensation amount to be paid by States to acid attack victims must be enhanced to at least Rs3 lakh.
The court also said of the compensation amount of Rs3 lakh, Rs1 lakh will be paid within 15 days of the occurrence of the attack being brought to the notice of the state government.
In its interim direction, the bench, said the licensed seller of acids and corrosive substances will have to maintain a log or register pertaining to the sale of such material. The register shall contain the addresses of the persons to whom such substances have been sold, it said.
Photo identity card, containing residential address issued by the authorities, would be required for purchasing such substances, which in any case cannot be sold to a person who is below the age of 18 years, the court said.
It also said sellers will have to disclose their stock to the authorities concerned, otherwise the undeclared stock would be confiscated and a suitable fine of up to Rs50,000 shall be imposed on such sellers.
However, the court said that educational institutes, research laboratories, hospitals, Government departments and public sector undertakings could acquire in bulk acids and corrosive substances by following certain guidelines.
A consortium including Sunil Gavaskar, Nagarjuna and Vankina Chamundeswaranath has bought stake in IBL’s Mumbai Masters
Contrary to media report about Sachin Tendulkar buying stake in Mumbai franchise of the upcoming Indian Badminton League (IBL), it was another cricket legend from Mumbai, Sunil Gavaskar, who has bought stake.
A consortioum of former cricket captain Gavaskar, Telugu actor Nagarjuna and former manager of the Indian cricket team and businessman Vankina Chamundeswaranath bought stake in IBL’s Mumbai franchise, called as Mumbai Masters.
In a release, Gavaskar said, “I am proud to be associated with badminton which I’ve always admired and passionately followed and played a bit as a fan. The sport has produced legends and recorded many milestones for India and I hope my association with the Indian Badminton League proves to be a worthy contribution to the great sport of badminton."
The $1 million league is set to launch on 14th August with some high-voltage action expected between PVP’s Hyderabad Hotshots and BOP Group’s Banga Beats.
A total of 90 matches will be played in the IBL which will feature six franchises, Mumbai, Pune, Hyderabad, Delhi, Bangalore and Lucknow.
The IBL will be held in six cities from 14th to 31st August. The tournament will feature some of the top-50 players in the world and will be played under the Sudirman Cup format and televised LIVE to more than 100 countries.
The apex court said Medical Council is not empowered to prescribe all India medical entrance tests. However, the SC made it clear that its verdict will not affect admissions, which have already taken place
The Supreme Court on Thursday quashed the Medical Council of India’s (MCI) notification for holding common entrance tests for Bachelor of Medicine and Bachelor of Surgery (MBBS), Bachelor of dental surgery (BDS) and post-graduate medical courses.
The majority, 2:1 verdict by Chief Justice Altamas Kabir and Justice Vikramajit Sen said that MCI is not empowered to prescribe all India medical entrance tests. Justice AR Dave said he did not share the view of Chief Justice Kabir and Justice Sen. A three-judge bench held that the MCI notification was ultra vires of the Constitution.
The apex court, however, made it clear that its verdict will not affect the admissions which have already taken place.
The court’s decision came on 115 petitions challenging the MCI notification on National Eligibility Entrance Test (NEET) for admission to MBBS and post-graduate medical courses conducted in colleges across the country.
Earlier in May this year, the apex court had lifted the bar on declaration of results of examinations that had already been conducted and said the admission process could go ahead.